Wealth Alliance Invests $221,000 in Doximity, Inc. (NASDAQ:DOCS)

Wealth Alliance bought a new position in Doximity, Inc. (NASDAQ:DOCS) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 4,145 shares of the company’s stock, valued at approximately $221,000.

Other large investors have also bought and sold shares of the company. Creative Planning boosted its stake in Doximity by 13.7% in the third quarter. Creative Planning now owns 22,104 shares of the company’s stock worth $963,000 after purchasing an additional 2,671 shares in the last quarter. Blue Trust Inc. raised its holdings in shares of Doximity by 107.2% in the third quarter. Blue Trust Inc. now owns 2,870 shares of the company’s stock valued at $125,000 after buying an additional 1,485 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in Doximity by 4.5% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 21,754 shares of the company’s stock worth $948,000 after buying an additional 934 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in Doximity by 7.4% during the 3rd quarter. State of Alaska Department of Revenue now owns 14,240 shares of the company’s stock worth $620,000 after acquiring an additional 985 shares during the last quarter. Finally, Smith Group Asset Management LLC increased its position in Doximity by 38.8% in the 3rd quarter. Smith Group Asset Management LLC now owns 9,940 shares of the company’s stock valued at $433,000 after acquiring an additional 2,780 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 37.40% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Leerink Partners upgraded shares of Doximity from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Leerink Partnrs upgraded shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. Raymond James reiterated an “outperform” rating and issued a $83.00 price objective (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. Finally, Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $33.00 to $53.00 in a research note on Thursday, November 14th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, Doximity currently has an average rating of “Moderate Buy” and an average target price of $64.22.

Doximity Stock Performance

Shares of NASDAQ:DOCS opened at $72.25 on Friday. The company has a 50 day moving average price of $60.19 and a two-hundred day moving average price of $49.21. The company has a market capitalization of $13.49 billion, a PE ratio of 72.25, a PEG ratio of 4.10 and a beta of 1.39. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.